Scholar Rock Holding Corporation
NASDAQ:SRRKBiotechnology
+$0.49 today
- Market cap
- $5.86B
- Beta
- 0.69
- P/E (TTM)
- -14.8
- EPS (TTM)
- -$3.21
Volume 2.77M
Average 1.46M
SRRK Change in Working Capital
Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.
Scholar Rock Holding CorporationNASDAQ: SRRK
Change in Working Capital · Q3 FY2026 · quarter ended Sep 2026
Change in working capital declines year over year
Q3 FY2026 change in working capital of $5.56M fell 68.3% year over year, ahead of the -96.4% change in trailing-twelve-month change in working capital. Sequentially, it rose 856.8% from the prior quarter. Over 3 fiscal years it compounded at -68.7% a year.
Context
- Change in working capital increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of -68.3% holds above the trailing-twelve-month pace of -96.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Change in Working Capital history
USD · from the cash flow
- Latest · FY2025
- (1.05M) USD
- Year-over-year change
- -115.9%
| Period | Period end | Change in Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.05M) | -115.9% |
| FY2024 | 2024-12-31 | 6.59M | +162.1% |
| FY2023 | 2023-12-31 | (10.61M) | +69.1% |
| FY2022 | 2022-12-31 | (34.39M) | -20.9% |
| FY2021 | 2021-12-31 | (28.44M) | — |
Change in Working Capital vs competitors
How SRRK compares with its peers on the latest reported figures
- SRRK's LTM Sep 2026 change in working capital of $560K is the smallest of the 11 companies compared; the peer median is $55.46M.
- Its year-over-year change of -96.4% is the 10th highest of 11, against a peer median of +132.1%.
- Change in working capital amounts to 98.2% of revenue for SRRK, versus a peer median of 16.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $226.44M | -66.1% | — | 10.4% | |
| LTM Sep 2026 | $160.4M | +161.3% | — | 16.7% | |
| LTM Jun 2026 | $138.77M | +102.9% | — | 88.9% | |
| LTM Jun 2026 | $94.28M | +1496.3% | -17.5% | 9.3% | |
| LTM Jun 2026 | $88.35M | +2.8% | — | 12.4% | |
| LTM Mar 2026 | $22.56M | +605.7% | -11.1% | 112.8% | |
| LTM Mar 2026 | $15.28M | +91.2% | -27.6% | 47.6% | |
| LTM Sep 2026 | $13.05M | +639.1% | — | — | |
| LTM Jun 2026 | $10.27M | -192.2% | -14.1% | — | |
| LTM Sep 2026 | $2.66M | +343.8% | — | — | |
| LTM Sep 2026 | $560K | -96.4% | -68.7% | 98.2% | |
| Peer median (excluding SRRK) | $55.46M | +132.1% | -15.8% | 16.7% | |
Competitors are the stored peer set for SRRK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (131.8M) | (134.5M) | (165.79M) | (246.29M) | (377.94M) |
| Depreciation & Amortization | 2.63M | 2.99M | 2.84M | 1.94M | 1.66M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 23.15M | 27.7M | 27.14M | 36.63M | 75.6M |
| Change in Working Capital | (28.44M) | (34.39M) | (10.61M) | 6.59M | (1.05M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 1.02M | (251K) | (529K) | 6.63M | 208K |
| Other Working Capital | (29.46M) | (34.14M) | (10.09M) | (36K) | (1.26M) |
| Other Non-Cash Items | 7.67M | 5.51M | 1.19M | 186K | 1.7M |
| Operating Cash Flow | (126.79M) | (132.69M) | (145.23M) | (200.95M) | (300.04M) |
| Capital Expenditures | (5.25M) | (1.06M) | (71K) | (98K) | (602K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (60.44M) | (300.63M) | (290.8M) | (293.16M) | (98.01M) |
| Sales of Investments | 200M | 130M | 332M | 217.2M | 317.3M |
| Other Investing Activities | 0 | 0 | 13K | 0 | 0 |
| Investing Cash Flow | 134.32M | (171.7M) | 41.14M | (76.06M) | 218.69M |
| Debt Repayment | 24.98M | (975K) | 0 | 0 | 49.14M |
| Common Stock Issued | 13.1M | 195.32M | 97.71M | 324.41M | 179.26M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 6.87M | 492K | 4.87M | 28.61M | 0 |
| Financing Cash Flow | 44.95M | 194.83M | 102.57M | 353.03M | 228.4M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | (2K) |
| Net Change in Cash | 52.48M | (109.56M) | (1.51M) | 76.02M | 147.05M |
| Free Cash Flow | (132.04M) | (133.76M) | (145.3M) | (201.05M) | (300.64M) |
Scholar Rock Holding Corporation
NASDAQ:SRRK
Intrinsic Alpha fair value
Locked
Current Price
$48.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.